Global Drug Industry Does About-Face

After decades of broadening their drug portfolios through acquisitions, pharmaceutical companies are reversing course to focus more narrowly on what they think they can do best.



from WSJ.com: US Business http://ift.tt/1mBXY6e

via IFTTT